PG · PROCTER & GAMBLE Co · Financials

On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).

Issuer evidence: On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).

Supporting evidence: On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).

On October 29, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 0.550% Notes due October 29, 2025 and $1,250,000,000 aggregate principal amount of 1.200% Notes due October 29, 2030 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Issuer evidence: On October 29, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 0.550% Notes due October 29, 2025 and $1,250,000,000 aggregate principal amount of 1.200% Notes due October 29, 2030 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Supporting evidence: On October 29, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 0.550% Notes due October 29, 2025 and $1,250,000,000 aggregate principal amount of 1.200% Notes due October 29, 2030 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

On April 23, 2021, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.000% Notes due April 23, 2026 and $1,000,000,000 aggregate principal amount of 1.950% Notes due April 23, 2031 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Issuer evidence: On April 23, 2021, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.000% Notes due April 23, 2026 and $1,000,000,000 aggregate principal amount of 1.950% Notes due April 23, 2031 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Supporting evidence: On April 23, 2021, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.000% Notes due April 23, 2026 and $1,000,000,000 aggregate principal amount of 1.950% Notes due April 23, 2031 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

On May 2, 2023, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2026 and €650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2031 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Issuer evidence: On May 2, 2023, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2026 and €650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2031 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Supporting evidence: On May 2, 2023, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2026 and €650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2031 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

On February 1, 2022, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.900% Notes due February 1, 2027 and $850,000,000 aggregate principal amount of 2.300% Notes due February 1, 2032 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Issuer evidence: On February 1, 2022, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.900% Notes due February 1, 2027 and $850,000,000 aggregate principal amount of 2.300% Notes due February 1, 2032 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Supporting evidence: On February 1, 2022, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.900% Notes due February 1, 2027 and $850,000,000 aggregate principal amount of 2.300% Notes due February 1, 2032 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).

Issuer evidence: On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).

Supporting evidence: On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).

On April 29, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €650,000,000 aggregate principal amount of 3.150% Notes due April 29, 2028 and €850,000,000 aggregate principal amount of 3.200% Notes due April 29, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

Issuer evidence: On April 29, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €650,000,000 aggregate principal amount of 3.150% Notes due April 29, 2028 and €850,000,000 aggregate principal amount of 3.200% Notes due April 29, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

Supporting evidence: On April 29, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €650,000,000 aggregate principal amount of 3.150% Notes due April 29, 2028 and €850,000,000 aggregate principal amount of 3.200% Notes due April 29, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

On January 29, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $600,000,000 aggregate principal amount of 4.350% Notes due January 29, 2029 and $750,000,000 aggregate principal amount of 4.550% Notes due January 29, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

Issuer evidence: On January 29, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $600,000,000 aggregate principal amount of 4.350% Notes due January 29, 2029 and $750,000,000 aggregate principal amount of 4.550% Notes due January 29, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

Supporting evidence: On January 29, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $600,000,000 aggregate principal amount of 4.350% Notes due January 29, 2029 and $750,000,000 aggregate principal amount of 4.550% Notes due January 29, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

On October 24, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $500,000,000 aggregate principal amount of 4.150% Notes due October 24, 2029 and $500,000,000 aggregate principal amount of 4.550% Notes due October 24, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

Issuer evidence: On October 24, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $500,000,000 aggregate principal amount of 4.150% Notes due October 24, 2029 and $500,000,000 aggregate principal amount of 4.550% Notes due October 24, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).

Issuer evidence: On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).

Supporting evidence: On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).

On May 1, 2025, The Procter & Gamble Company (the "Company") closed an underwritten public offering of $700,000,000 aggregate principal amount of 4.050% Notes due May 1, 2030 and $550,000,000 aggregate principal amount of 4.600% Notes due May 1, 2035 under the Company's Registration Statement on Form S-3 (Registration No. 333-275071). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Issuer evidence: On May 1, 2025, The Procter & Gamble Company (the "Company") closed an underwritten public offering of $700,000,000 aggregate principal amount of 4.050% Notes due May 1, 2030 and $550,000,000 aggregate principal amount of 4.600% Notes due May 1, 2035 under the Company's Registration Statement on Form S-3 (Registration No. 333-275071). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

On November 5, 2021, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €500,000,000 aggregate principal amount of 0.350% Notes due May 5, 2030 and €600,000,000 aggregate principal amount of 0.900% Notes due November 4, 2041 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545).

Issuer evidence: On November 5, 2021, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €500,000,000 aggregate principal amount of 0.350% Notes due May 5, 2030 and €600,000,000 aggregate principal amount of 0.900% Notes due November 4, 2041 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545).

Supporting evidence: On November 5, 2021, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €500,000,000 aggregate principal amount of 0.350% Notes due May 5, 2030 and €600,000,000 aggregate principal amount of 0.900% Notes due November 4, 2041 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545).

On October 29, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 0.550% Notes due October 29, 2025 and $1,250,000,000 aggregate principal amount of 1.200% Notes due October 29, 2030 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Issuer evidence: On October 29, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 0.550% Notes due October 29, 2025 and $1,250,000,000 aggregate principal amount of 1.200% Notes due October 29, 2030 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Supporting evidence: On October 29, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 0.550% Notes due October 29, 2025 and $1,250,000,000 aggregate principal amount of 1.200% Notes due October 29, 2030 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

On April 23, 2021, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.000% Notes due April 23, 2026 and $1,000,000,000 aggregate principal amount of 1.950% Notes due April 23, 2031 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Issuer evidence: On April 23, 2021, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.000% Notes due April 23, 2026 and $1,000,000,000 aggregate principal amount of 1.950% Notes due April 23, 2031 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Supporting evidence: On April 23, 2021, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.000% Notes due April 23, 2026 and $1,000,000,000 aggregate principal amount of 1.950% Notes due April 23, 2031 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

On May 2, 2023, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2026 and €650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2031 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Issuer evidence: On May 2, 2023, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2026 and €650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2031 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Supporting evidence: On May 2, 2023, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2026 and €650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2031 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

On February 1, 2022, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.900% Notes due February 1, 2027 and $850,000,000 aggregate principal amount of 2.300% Notes due February 1, 2032 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Issuer evidence: On February 1, 2022, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.900% Notes due February 1, 2027 and $850,000,000 aggregate principal amount of 2.300% Notes due February 1, 2032 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Supporting evidence: On February 1, 2022, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.900% Notes due February 1, 2027 and $850,000,000 aggregate principal amount of 2.300% Notes due February 1, 2032 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

On January 29, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $600,000,000 aggregate principal amount of 4.350% Notes due January 29, 2029 and $750,000,000 aggregate principal amount of 4.550% Notes due January 29, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

Issuer evidence: On January 29, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $600,000,000 aggregate principal amount of 4.350% Notes due January 29, 2029 and $750,000,000 aggregate principal amount of 4.550% Notes due January 29, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

Supporting evidence: On January 29, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $600,000,000 aggregate principal amount of 4.350% Notes due January 29, 2029 and $750,000,000 aggregate principal amount of 4.550% Notes due January 29, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

On April 29, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €650,000,000 aggregate principal amount of 3.150% Notes due April 29, 2028 and €850,000,000 aggregate principal amount of 3.200% Notes due April 29, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

Issuer evidence: On April 29, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €650,000,000 aggregate principal amount of 3.150% Notes due April 29, 2028 and €850,000,000 aggregate principal amount of 3.200% Notes due April 29, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

Supporting evidence: On April 29, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €650,000,000 aggregate principal amount of 3.150% Notes due April 29, 2028 and €850,000,000 aggregate principal amount of 3.200% Notes due April 29, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

On October 24, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $500,000,000 aggregate principal amount of 4.150% Notes due October 24, 2029 and $500,000,000 aggregate principal amount of 4.550% Notes due October 24, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

Issuer evidence: On October 24, 2024, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $500,000,000 aggregate principal amount of 4.150% Notes due October 24, 2029 and $500,000,000 aggregate principal amount of 4.550% Notes due October 24, 2034 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

On May 1, 2025, The Procter & Gamble Company (the "Company") closed an underwritten public offering of $700,000,000 aggregate principal amount of 4.050% Notes due May 1, 2030 and $550,000,000 aggregate principal amount of 4.600% Notes due May 1, 2035 under the Company's Registration Statement on Form S-3 (Registration No. 333-275071). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Issuer evidence: On May 1, 2025, The Procter & Gamble Company (the "Company") closed an underwritten public offering of $700,000,000 aggregate principal amount of 4.050% Notes due May 1, 2030 and $550,000,000 aggregate principal amount of 4.600% Notes due May 1, 2035 under the Company's Registration Statement on Form S-3 (Registration No. 333-275071). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).

Issuer evidence: On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).

Supporting evidence: On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).

On November 5, 2021, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €500,000,000 aggregate principal amount of 0.350% Notes due May 5, 2030 and €600,000,000 aggregate principal amount of 0.900% Notes due November 4, 2041 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545).

Issuer evidence: On November 5, 2021, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €500,000,000 aggregate principal amount of 0.350% Notes due May 5, 2030 and €600,000,000 aggregate principal amount of 0.900% Notes due November 4, 2041 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545).

Supporting evidence: On November 5, 2021, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €500,000,000 aggregate principal amount of 0.350% Notes due May 5, 2030 and €600,000,000 aggregate principal amount of 0.900% Notes due November 4, 2041 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545).

On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).

Issuer evidence: On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).

Supporting evidence: On March 25, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Company’s Registration Statement on Form S-3 (Registration No. 333-221035).

On November 16, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $197,067,000 aggregate principal amount of Floating Rate Notes due November 16, 2070 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Issuer evidence: On November 16, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $197,067,000 aggregate principal amount of Floating Rate Notes due November 16, 2070 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Supporting evidence: On November 16, 2020, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $197,067,000 aggregate principal amount of Floating Rate Notes due November 16, 2070 under the Company’s Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

On February 8, 2022, The Procter & Gamble Company (the "Company") closed an underwritten public offering of $412,533,000 aggregate principal amount of Floating Rate Notes due February 8, 2072 under the Company's Registration Statement on Form S-3 (Registration No. 333-249545).

Issuer evidence: On February 8, 2022, The Procter & Gamble Company (the "Company") closed an underwritten public offering of $412,533,000 aggregate principal amount of Floating Rate Notes due February 8, 2072 under the Company's Registration Statement on Form S-3 (Registration No. 333-249545).

Supporting evidence: On February 8, 2022, The Procter & Gamble Company (the "Company") closed an underwritten public offering of $412,533,000 aggregate principal amount of Floating Rate Notes due February 8, 2072 under the Company's Registration Statement on Form S-3 (Registration No. 333-249545).

On February 3, 2023, The Procter & Gamble Company (the "Company") closed an underwritten public offering of $482,886,000 aggregate principal amount of Floating Rate Notes due February 3, 2073 under the Company's Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Issuer evidence: On February 3, 2023, The Procter & Gamble Company (the "Company") closed an underwritten public offering of $482,886,000 aggregate principal amount of Floating Rate Notes due February 3, 2073 under the Company's Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

Supporting evidence: On February 3, 2023, The Procter & Gamble Company (the "Company") closed an underwritten public offering of $482,886,000 aggregate principal amount of Floating Rate Notes due February 3, 2073 under the Company's Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference.

On November 1, 2023, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $256,534,000 aggregate principal amount of Floating Rate Notes due November 1, 2073 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

Issuer evidence: On November 1, 2023, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $256,534,000 aggregate principal amount of Floating Rate Notes due November 1, 2073 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

Supporting evidence: On November 1, 2023, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $256,534,000 aggregate principal amount of Floating Rate Notes due November 1, 2073 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

On November 4, 2025, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $258,889,000 aggregate principal amount of Floating Rate Notes due November 4, 2075 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).

Issuer evidence: On November 4, 2025, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $258,889,000 aggregate principal amount of Floating Rate Notes due November 4, 2075 under the Company’s Registration Statement on Form S-3 (Registration No. 333-275071).